Mobia Medical, Inc. MOBI
Mobia Medical, Inc. (Nasdaq: MOBI) is a CNS/neurology/psychiatry medical device company. Its next catalyst on record is GRASP registry: Publication of 12-, 24-, and 36-month outcomes (date not stated).
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Next further out: GRASP registry — Publication of 12-, 24-, and 36-month outcomes (date not stated). 1 catalyst on record beyond the next 30 days; subscribers see each with its filing sentence.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| Vivistim Paired VNS System | Chronic ischemic stroke survivors with moderate to severe upper extremity impairments | device-combination | Approved |
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
Other approved CNS/neurology/psychiatry companies
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.